Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its CEO, Rob Fried, will ...
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...
16h
Daré Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event
PM ETRegister here SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: DARE), a purpose-driven health biotech company ...
Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...
Recently listed, Satellos Bioscience Inc. MSLE on Wednesday reported six-month interim data from its ongoing TRAILHEAD study ...
Zacks Investment Research on MSN
Implied volatility surging for Niagen Bioscience stock options
Investors in Niagen Bioscience, Inc. NAGE need to pay close attention to the stock based on moves in the options market lately. That is because the Aug. 21, 2026 $12.50 Call had some of the highest ...
All four participants showed a decline in fat fraction as measured by MRI, with a mean improvement of 3.7% from 49.7% at TRAILHEAD baseline to 46.0% at month 6, suggesting improved muscle composition ...
Niagen Bioscience is back in focus after analysts cut their combined price targets by US$5 while still holding the fair value estimate steady at US$12.60. The adjustment reflects fresh scrutiny of the ...
As America approaches its 250th anniversary, the companies will pursue the development of scalable seedling technologies to support the first-ever restoration of a native tree species from functional ...
Shares of Satellos Bioscience rose after it reported its investigational drug candidate SAT-3247 for adults living with Duchenne muscular dystrophy showed positive results. The stock was up 16% to $9.
View Regencell Bioscience Holdings Ltd. RGC stock quote prices, financial information, real-time forecasts, and company news from CNN.
Rua Bioscience Limited has requested and received a trading halt on its ordinary shares on the NZX, effective immediately, after signing an agreement with an international counterparty based in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results